Skip to main content

Table 4 Characteristics of different skin ADRs

From: The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy

Skin ADRs

Mean score

(x ± s)

Incidence

(%)

 ≥ 3 Level

Incidence (%)

Manifestation

Average time of occurrence

Location

Concomitant symptoms

Rash

2.27 ± 1.68

75

30.1

Papule; Macula; Pustule

21 days

Face (87%); Back and chest (69%); Lower limbs (38%); Abdomen (26%)

Itch; Pain; Skin burning; Skin tightness

Hand-foot syndrome

2.02 ± 0.82

53.4

18.6

Skin redness; Pain; Swelling; Numbness

32 days

Palms and soles

Increased skin sensitivity;

Skin peeling, blisters, bleeding, chapping, and excessive keratosis

Xerosis

1.94 ± 0.79

41.6

11.5

The skin becomes thin, shriveled, blackened, unresponsive; Skin wrinkles and skin aging

42 days

Limbs

Skin cracks; Pain; Itch;

Blooding; Desquamation

Pruritus

2.02 ± 1.40

26.7

8.9

Itch; Dry

53 days

Systemic or local

Edema; Papules; Lichenification; Sclerosis, Exudation; Crusting

Nail change

1.40 ± 0.49

15.2

0

Granuloma around nails

49 days

Nails and tissues around nails

Pain; Suppuration; Erythema; Swelling; Lateral nail fissure

Nail loss

1.39 ± 0.49

7.8

0

The nail bed is separated from the deck

38 days

Nails

Paronychia; Infection;

Nail falling off; Nail lesions

Hair loss

1.56 ± 0.50

17.6

0

Hair loss; Hair curly, thin and fragile

33 days

Head; Eye; Face

Eyelashes are thick, long and curly; Facial hairiness